Thrombolytics in CPR: Current advantages in cardiopulmonary resuscitation

Minerva Anestesiologica

Volumn 71, Issue 6, 2005, Pages 291-296

  Spohr F ^a   Böttiger, Bernd W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiopulmonary resuscitation; Controlled clinical study; Haemorrhage; Myocardial infarction; Pulmonary embolism; Thrombolytic therapy

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; TENECTEPLASE; UROKINASE;

ACUTE HEART INFARCTION; BLEEDING; BRAIN PERFUSION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; LUNG EMBOLISM; MICROCIRCULATION; PROGNOSIS; RESUSCITATION; REVIEW; TREATMENT OUTCOME;

CARDIOPULMONARY RESUSCITATION; CLINICAL TRIALS; EMERGENCY MEDICAL SERVICES; HEART ARREST; HUMANS; MYOCARDIAL INFARCTION; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY;

EID: 21644449915     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346: 549-56.
2. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
3. Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Intern Med 1991;229:331-5.
4. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629-33.
5. Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999;115:1695-707.
6. Padosch SA, Motsch J, Böttiger BW. Thrombolysis during cardiopulmonary resuscitation. Anaesthesist 2002;51:516-32.
7. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004;110:588-636.
8. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
9. Böttiger B. Thrombolysis during cardiopulmonary resuscitation. Fibrinolysis 1997;11 Suppl 2:93-100.
10. Fischer M, Böttiger BW, Popov-Cenic S, Hossmann KA. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 1996;22:1214-23.
11. Böttiger BW, Motsch J, Böhrer H, Böker T, Aulmann M, Nawroth PP et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 1995;92:2572-8.
12. Böttiger BW, Böhrer H, Bach A, Motsch J, Martin E, Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation 1994;28:45-54.
13. Köhle W, Pindur G, Stauch M, Rasche H. Hochdosierte Streptokinasetherapie bei fulminanter Lungenarte-rienembolie. Anaesthesist 1984;33:469.
14. Gramann J, Lange-Braun P, Bodemann T, Hochrein H. Der Einsatz von Thrombolytika in der Reanimation als Ultima ratio zur üUberwindung des Herztodes. Intensivund Notfallbehandlung 1991:16:134-7.
15. Kürkciyan I, Meron G, Sterz F, Janata K, Domanovits H, Holzer M et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 2000;160:1529-35.
16. Kleiner DM, Ferguson KL, King K, Bozeman WP. Empiric tenecteplase use in cardiac arrest refractory to standard advanced cardiac life support interventions. Circulation 2003;108 Suppl IV: 318-9.
17. Fatovich DM, Dobb GJ, Clugston RA. A pilot randomised trial of thrombolysis in cardiac arrest (The TICA trial). Resuscitation 2004;61:309-13.
18. Ballew KA, Philbrick JT, Caven DE, Schorling JB. Predictors of survival following in-hospital cardiopulmonary resuscitation. A moving target. Arch Intern Med 1994;154:2426-32.
19. Bedell SE, Delbanco TL, Cook EF, Epstein FH. Survival after cardiopulmonary resuscitation in the hospital. N Engl J Med 1983;309:569-76.
20. Böttiger BW, Grabner C, Bauer H, Bode C, Weber T, Motsch ME. Long term outcome after out-of-hospital cardiac arrest with physician staffed emergency medical services: the Utstein style applied to a midsized urban/suburban area. Heart 1999;82:674-9.
21. Klefisch F, Gareis R, Störk T, Möckel M, Danne O. Präklinische ultima-ratio Thrombolyse bei therapiere-fraktärer kardiopulmonaler Reanimation. Intensivmedizin 1995;32:155-62.
22. Böttiger BW, Bode C, Kern S, Gries A, Gust R, Glätzer R et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001;357:1583-5.
23. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 2001;50:71-6.
24. Abu-Laban RB, Christenson JM, Innes GD, van Beek CA, Wanger KP, McKnight RD et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002;346:1522-8.
25. Böttiger BW, Padosch SA, Wenzel V, Paradis NA, Knaut A, Halperin H et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002;17:1281-2.
26. Spöhr F, Arntz HR, Bluhmki E, Bode C, Carli P, Chamberlain D et al. International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: The Thrombolysis in Cardiac Arrest (TROICA) study. Eur J Clin Invest 2005; in press.
27. Califf RM, Fortin DF, Tenaglia AN, Sane DC. Clinical Risks of Thrombolytic Therapy. Am J Cardiol 1992;69: 12A-20A.
28. Spöhr F, Böttiger BW. Safety of thrombolysis during cardiopulmonary resuscitation. Drug Saf 2003;26:367-79.
29. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343:311-22.
30. Kanter DS, Mikkola KM, Patel SR, Parker JA, Goldhaber SZ. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest 1997; 111: 1241-5.
31. Scholz KH, Hilmer T, Schuster S, Wojcik J, Kreuzer H, Tebbe U. Thrombolysis in resuscitated patients with pulmonary embolism. Dtsch Med Wochenschr 1990;115:930-5.
32. Scholz KH, Tebbe U, Herrmann C, Wojcik J, Lingen R, Chemnitius JM et al. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol 1992;69:724-8.